Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Anemia, Aplastic (Phase 1/Phase 2)
Anemia, Diamond-Blackfan (Phase 1/Phase 2)
Anemia, Sickle Cell (Phase 1/Phase 2)
Congenital Bone Marrow Failure Syndromes (Phase 1)
Fanconi Anemia (Phase 1/Phase 2)
Hematologic Neoplasms (Phase 1)
Hemoglobinopathies (Phase 1/Phase 2)
Leukemia (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 1)
Lymphohistiocytosis, Hemophagocytic (Phase 1)
Lymphoma (Phase 1/Phase 2)
Lymphoma, Non-Hodgkin (Phase 1/Phase 2)
Metabolic Diseases (Phase 1)
Multiple Myeloma (Phase 1)
Myelodysplastic Syndromes (Phase 1/Phase 2)
Myeloproliferative Disorders (Phase 1)
Neoplasms (Phase 1)
Osteopetrosis (Phase 1/Phase 2)
Pediatrics (Phase 2)
Plasmacytoma (Phase 1)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 1/Phase 2)
Primary Immunodeficiency Diseases (Phase 2)
Thalassemia (Phase 1/Phase 2)
Thrombocytopenia (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
